Jan Elias Hansen, PhD Assumes Role of President

Lawrenceville, NJ, USA—May 23, 2022—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the results of its recent elections. The Society’s membership selected its new president-elect. The 2022-2023 board is assuming office on July 1 and includes the following members.

Jan Elias Hansen, PhD—President
Dr Hansen will assume the role of 2022-2023 president after having served as ISPOR’s president-elect over the past year. She is a vice president of the Evidence for Access Unit in US Medical Affairs at Genentech in South San Francisco, California, USA.

Brian O’Rourke, PharmD—President-Elect
Dr O’Rourke was elected as president-elect and will move into the role of president during the 2023-2024 term. He is president of Brian O’Rourke Health Care Consulting, Inc in Ottawa, ON, Canada.

Isao Kamae, MD, DrPH—Immediate Past President
Professor Kamae moves into the role of immediate past president. He is a project professor, health policy and technology assessment at the Graduate School of Public Policy, The University of Tokyo in Tokyo, Japan.

Returning board members include:

Beth Devine, PhD—Director
Dr Devine is a professor and graduate program director at the Comparative Heath Outcomes, Policy and Economics Institute, School of Pharmacy, University of Washington in Seattle, Washington, USA.

Marlene Gyldmark, MPhil—Director
Ms Gyldmark is global head outcomes research, health economics and health policy at Roche Diabetes Care in Basel, Switzerland.

Andrea Manca, MSc, PhD—Director
Dr Manca is a professor of health economics at the Centre for Health Economics, University of York in York, England, UK.

Eberechukwu Onukwugha, MS, PhD—Director
Dr Onukwugha is an associate professor in the Department of Pharmaceutical Health Services and is the executive director of the Pharmaceutical Research Computing Center at the University of Maryland School of Pharmacy in Baltimore, Maryland, USA.

Lotte Steuten, MPhil—Director
Dr Steuten is vice president and head of consulting at the Office of Health Economics and honorary visiting professor at the University of London in London, England, UK.

Dong-Churl Suh, PhD—Director
Dr Suh is a professor and director, pharmaceutical economics and policy at the College of Pharmacy, Chung-Ang University in Seoul, South Korea.

David Thompson, PhD—Director
Dr Thompson is senior vice president, real-world research at Syneos Health in Boston, Massachusetts, USA.

Sean D. Sullivan, BScPharm, MSc, PhD—Treasurer
Dr Sullivan is professor and dean at the University of Washington, School of Pharmacy in Seattle, Washington, USA.

Nancy S. Berg—CEO & Executive Director
Ms Berg is chief executive officer and executive director at ISPOR—The Professional Society for Health Economics and Outcomes Research in Lawrenceville, New Jersey, USA.

###

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE^®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram